Reviewers Give Thumbs Down to Corporate Deal at Berkeley

By GOLDIE BLUMENSTYK

A team of outside scholars invited by the University of California at Berkeley to evaluate its unusual and controversial research agreement with the company formerly known as Novartis says Berkeley, and other universities, should avoid similar arrangements in the future.

The arrangement at Berkeley, in which nearly an entire biology...

To continue reading this premium article, you must have a Chronicle account AND a subscription or an online pass.

Subscriptions start at $40; Web passes for under $10.

If you have a Chronicle account:

Log in now.

User name

Password

 

Remember my user name
Forgot your user name?
Forgot your password?
Log in tips

Don't have a Chronicle account?

Create a free account to purchase a subscription or an online pass.

Your free account also allows you to sign up for Chronicle e-newsletters, participate in online discussions, and more…